clinical context
Articles tagged with “clinical context”
Which Ketamine Routes Require In-Clinic Supervision?
IV, IM, and esketamine (Spravato) require in-clinic supervision; sublingual and some intranasal routes often don't. See which routes need monitoring and why.
Compounded Ketamine Safety Oversight: What to Know
Compounded ketamine is not FDA-reviewed for safety or potency. Learn who regulates it, the real risks, and what to ask before starting treatment in 2026.
Ketamine Half-Life by Route of Administration Explained
Ketamine's half-life is about 2-3 hours for IV, IM, and oral doses, but 7-12 hours for esketamine (Spravato). Compare routes now.
Epidural and Intrathecal Ketamine in Clinical Use
Epidural and intrathecal ketamine is an off-label neuraxial technique used mainly in pain medicine, not psychiatry. See how it works and its risks.
Buccal Ketamine: Absorption Rate and Clinical Use
How buccal ketamine absorbs through the cheek, its bioavailability compared with IV and IM routes, and how it's used off-label. Compare methods now.
Ketamine Onset Time by Route: What the Research Shows
How quickly does ketamine work? Onset ranges from 30 seconds (IV) to 30 minutes (oral). Compare bioavailability, duration, and supervision needs by route.
Compounded Ketamine vs Spravato: Key Differences Explained
Compare compounded ketamine and Spravato (esketamine): FDA approval, bioavailability, supervision requirements, and clinical access differences.
Contact Ketamine Resource
Send corrections, partnership questions, or advertising inquiries.